• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Chiliz Has Lift Off

Chiliz (CHZ) surged 11.3% this week to $0.0443, outpacing the broader crypto market, where Bitcoin (BTC) advanced 8.5% to $120,140. With BTC breaking above the $117,000–$119,000 resistance zone, momentum is building for a potential rally toward $155,000–$165,000, creating a supportive backdrop for altcoins.

CHZ is capitalising on this strength after breaking out of a triangle pattern. The token is now targeting resistance at $0.0500, with a potential extension towards $0.0750. Such a move would offer investors gains of up to 70%.

55
B
Big Pharma Generates Wider Stream Of Income

US-rooted pharma businesses have significantly grown over the last 48 hours, with some of them getting double digits of its share price increase. This was due to a deal made with the Trump cabinet, which included direct selling of prescription drugs to consumers through the new website for Americans to buy necessary medicine, called TrumpRx.com, launching in 2026. The move is going to cut out so many middlemen like pharmacy chains, insurers and other beneficiaries to bring drug prices down. Good for patients, good for a stronger rebound in the industry, good for the promises of president Trump, who has said more than once that he wanted to make Americans the "most favored nation" in terms of pharmaceutical pricing and tariffs against the current situation when most US patients often pay nearly three times more for prescription medicaments than in other developed nations. Eli Lilly (LLY), Merck (MRK), Pfizer (PFE) and others in recent months have made pledges to boost their US manufacturing investment after Trump’s threats on higher trans border levies, and now this is happily settled down. "The United States is done subsidizing the healthcare of the rest of the world," Trump proclaimed when speaking at the Oval Office event, where he was accompanied by Pfizer CEO Albert Bourla and Health Secretary Robert F. Kennedy Jr. Trump added that Pfizer would offer that "most-favored-nation" pricing on all of its drugs within the Medicaid program for 70 million low-income Americans in exchange for tariff relief while other drug makers will "follow suit". Eli Lilly has been "fantastic" in these negotiations, according to Trump, which helped Eli Lilly share price to soar by more than 8% on the first trading day of October to reach $825 compared to just above $725 in early US morning of September 30.

It's not a surprise to me and my readers, as we discussed earlier that Eli Lilly seemed ready for a take-off from its previous price corridor at any moment after a set of successful trials of its much more convenient daily weight loss pill instead of injections. Now Eli Lilly has won the most by getting such an impressive boost together with all other representatives of the pharma industry. It is all now transforming into new fuel to generate an even wider stream of income for Wall Street investors. This is another powerful driver for stock indexes following the AI-based long-term factor, which has already allowed the S&P 500 to set a new historical record above 6,725 points overnight.

Merck added 7.4% only this Wednesday to probably end its lasting correction pattern since summer 2024. Shares of Pfizer rose by 6.8% during the same trading session, but still continue its bottoming between $25 and $30, as the firm is not yet able to recover from post-pandemic losses, when people no longer need large quantities of COVID vaccines. Abbvie (ABBV) gained 5.55%, reaching a fresh all-time peak for its market value. It's now $244.38 per share, up from just over $220 a couple of days ago. As for Eli Lilly, I personally bet on at least a range from $925 to $950 per share, that is on a more than $100 of further rise in the coming months, of which at least half may occur within several weeks.

109
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Graph Is Inspired by Weak U.S. Labour Market

The Graph (GRT) is up 6.3% this week to $0.0863, keeping pace with Bitcoin (BTC), which advanced 6.8% to $118,523. The crypto market is rallying despite the U.S. government shutdown, buoyed by signs of labour market weakness. September’s ADP Nonfarm Payrolls showed a surprise decline of 32,000 jobs versus expectations for a 52,000 increase, reinforcing bets on Federal Reserve rate cuts.

The Graph project is also showing renewed activity. In early September, it introduced an update enabling human-readable queries to access token information. From a technical perspective, GRT’s seven-month consolidation appears to be nearing completion. A decisive move above $0.1000 would likely open the way towards $0.1500.

106
RBA and ADP Now Playing for Bulls

Global equities scored additional support this week with interest rate policy hints from the Reserve Bank of Australia (RBA). Although the RBA decided to keep its key official borrowing cost level unchanged at 3.60%, also containing some hawkish notes in afterward comments, markets are betting on slashing Australian interest rates later in November. The RBA said recent inflation gauges pointed moderately higher than it was previously expected, so that the economy does not require emergency support, but a lasting recovery in national business activity may need regulatory help in the future. Australian central bankers are more inclined to pause, then wait and see after assessing the further dynamic, in clear contrast with U.S. Federal Reserve's signalling that its monetary policy needs to be eased before the end of the year, following the already made 0.25% rate cut move on September 17. This built a temporary divergence between Australian and U.S. monetary paths to work in favour of holding neutral AUDUSD positions exactly at the moment when the Greenback becomes weaker against Gold futures, Japanese Yen, Chinese Yuan and some European rivals. However, lower Dollar quotes are as good for stock prices on Wall Street as an inevitability of lower interest rates at various countries and continents, because lower rates make credit money more accessible for investing those money in enhancing stock portfolios, while lower Dollar as the unit of measurement for U.S. stock assets also promise to make stocks more expensive. Indeed, all driving stocks of the global digital industry, be it Google or Nvidia as the first examples just now coming on mind, will be worth excessively 10% if the USD as their price's unit loses the same 10% due to repeating sell-offs of the US Dollar as a funding currency for shares like Google, Nvidia and many others. We see obvious proof of this in a so fast pick-up of the broad S&P 500 index price from intraday lows around 6,630 this Wednesday, October 1, following persistently upside trend in precious metals and still weakening Dollar. Nvidia has already shown its freshest all-time high of around $187.30 on this development only one day before.

Meanwhile, the crowd's attention is turning to the possible publication of September’s nonfarm payrolls, scheduled on October 3. Cooling jobs picture has formed exactly a major focus for the Federal Reserve's projections two weeks ago. Therefore, further job weakness may be a long-playing positive factor for converting even more money into U.S. equities. Today's report by the U.S. Automatic Data Processing (ADP) service played on the same bullish side for Wall Street after showing the biggest private nonfarm payroll drop in 2.5 years. American businesses altogether shed a seasonally adjusted 32,000 jobs instead of adding 45,000 jobs in average expert forecasts.

Even though ADP data doesn't really correlate with official Nonfarm payrolls from the Bureau of Labour Statistics (BLS), its directional messages of poorer steam of U.S. economy is so clear, and poorer jobs means more investors-friendly Fed policy moves to normalise jobs, and both factors may only contribute into ever-growing Wall St sentiment.

126
1

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors